Airway Therapeutics, Zelpultide Alfa, NIH Grant, Bronchopulmonary Dysplasia, BPD, Premature Infants, Neonatal Medicine, Phase 2b/3

Cincinnati, Ohio, U.S., September 30, 2026 Airway Therapeutics, Inc. has been awarded a $1.9 million grant from the National...